Entry
Name
IL-17 signaling pathway - Homo sapiens (human)
Description
The interleukin 17 (IL-17) family, a subset of cytokines consisting of IL-17A-F, plays crucial roles in both acute and chronic inflammatory responses. IL-17A, the hallmark cytokine of the newly defined T helper 17 (TH17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease, whereas IL-17F is mainly involved in mucosal host defense mechanisms. IL-17E (IL-25) is an amplifier of Th2 immune responses. IL-17C has biological functions similar to those of IL-17A. The functions of IL-17B and IL-17D remain largely elusive. The IL-17 family signals via their correspondent receptors and activates downstream pathways that include NF-kappaB, MAPKs and C/EBPs to induce the expression of antimicrobial peptides, cytokines and chemokines. The receptor proximal adaptor Act1 (an NF-kappaB activator 1) is considered as the master mediator in IL-17A signaling. It is likely that Act1 is a common signal adaptor also shared by other members mediated signalings in this family.
Class
Organismal Systems; Immune system
BRITE hierarchy
Pathway map
Drug
D10902 Afasevikumab (USAN/INN)
Other DBs
Organism
Homo sapiens (human) [GN:
hsa ]
Gene
1051 CEBPB; CCAAT enhancer binding protein beta [KO:K10048 ]
10758 TRAF3IP2; TRAF3 interacting protein 2 [KO:K21124 ]
1147 CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467 ] [EC:2.7.11.10 ]
1437 CSF2; colony stimulating factor 2 [KO:K05427 ]
1440 CSF3; colony stimulating factor 3 [KO:K05423 ]
1994 ELAVL1; ELAV like RNA binding protein 1 [KO:K13088 ]
23118 TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404 ]
2353 FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379 ]
2354 FOSB; FosB proto-oncogene, AP-1 transcription factor subunit [KO:K09029 ]
257397 TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793 ]
2919 CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505 ]
2920 CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505 ]
2921 CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505 ]
3320 HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079 ]
3326 HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079 ]
338324 S100A7A; S100 calcium binding protein A7A [KO:K21126 ]
3576 CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030 ]
3627 CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671 ]
3725 JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448 ]
3727 JUND; JunD proto-oncogene, AP-1 transcription factor subunit [KO:K04449 ]
4322 MMP13; matrix metallopeptidase 13 [KO:K07994 ] [EC:3.4.24.-]
4586 MUC5AC; mucin 5AC, oligomeric mucus/gel-forming [KO:K13908 ]
4790 NFKB1; nuclear factor kappa B subunit 1 [KO:K02580 ]
51433 ANAPC5; anaphase promoting complex subunit 5 [KO:K03352 ]
5970 RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735 ]
6278 S100A7; S100 calcium binding protein A7 [KO:K21126 ]
6279 S100A8; S100 calcium binding protein A8 [KO:K21127 ]
6280 S100A9; S100 calcium binding protein A9 [KO:K21128 ]
6347 CCL2; C-C motif chemokine ligand 2 [KO:K14624 ]
6354 CCL7; C-C motif chemokine ligand 7 [KO:K05509 ]
6356 CCL11; C-C motif chemokine ligand 11 [KO:K16597 ]
6361 CCL17; C-C motif chemokine ligand 17 [KO:K21083 ]
6364 CCL20; C-C motif chemokine ligand 20 [KO:K14625 ]
6372 CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506 ]
6374 CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506 ]
6426 SRSF1; serine and arginine rich splicing factor 1 [KO:K12890 ]
7184 HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487 ]
7187 TRAF3; TNF receptor associated factor 3 [KO:K03174 ]
7188 TRAF5; TNF receptor associated factor 5 [KO:K09849 ]
727897 MUC5B; mucin 5B, oligomeric mucus/gel-forming [KO:K13908 ]
8061 FOSL1; FOS like 1, AP-1 transcription factor subunit [KO:K04502 ]
8517 IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210 ]
8717 TRADD; TNFRSF1A associated via death domain [KO:K03171 ]
8772 FADD; Fas associated via death domain [KO:K02373 ]
9618 TRAF4; TNF receptor associated factor 4 [KO:K09848 ]
9641 IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211 ] [EC:2.7.11.10 ]
Reference
Authors
Song X, Qian Y
Title
IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases.
Journal
Reference
Authors
Song X, Qian Y
Title
The activation and regulation of IL-17 receptor mediated signaling.
Journal
Reference
Authors
Gu C, Wu L, Li X
Title
IL-17 family: cytokines, receptors and signaling.
Journal
Reference
Authors
Gaffen SL, Jain R, Garg AV, Cua DJ
Title
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.
Journal
Reference
Authors
Iwakura Y, Ishigame H, Saijo S, Nakae S
Title
Functional specialization of interleukin-17 family members.
Journal
Reference
Authors
Qian Y, Kang Z, Liu C, Li X
Title
IL-17 signaling in host defense and inflammatory diseases.
Journal
Reference
Authors
Zhu S, Qian Y
Title
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Journal
Reference
Authors
Zenobia C, Hajishengallis G
Title
Basic biology and role of interleukin-17 in immunity and inflammation.
Journal
Reference
Authors
Reynolds JM, Angkasekwinai P, Dong C
Title
IL-17 family member cytokines: regulation and function in innate immunity.
Journal
Reference
Authors
Gaffen SL
Title
Recent advances in the IL-17 cytokine family.
Journal
Reference
Authors
Gaffen SL
Title
An overview of IL-17 function and signaling.
Journal
Reference
Authors
Hu Y, Shen F, Crellin NK, Ouyang W
Title
The IL-17 pathway as a major therapeutic target in autoimmune diseases.
Journal
Reference
Authors
Xu S, Cao X
Title
Interleukin-17 and its expanding biological functions.
Journal
Reference
Authors
Pappu R, Ramirez-Carrozzi V, Ota N, Ouyang W, Hu Y
Title
The IL-17 family cytokines in immunity and disease.
Journal
Reference
Authors
Gaffen SL
Title
Structure and signalling in the IL-17 receptor family.
Journal
Reference
Authors
Shen F, Gaffen SL
Title
Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.
Journal
Reference
Authors
Doyle MS, Collins ES, FitzGerald OM, Pennington SR
Title
New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis.
Journal
Reference
Authors
Gaffen SL, Kramer JM, Yu JJ, Shen F
Title
The IL-17 cytokine family.
Journal
Reference
Authors
Chang SH, Dong C
Title
Signaling of interleukin-17 family cytokines in immunity and inflammation.
Journal
Reference
Authors
Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M, Barnes JL, Chandrasekar B
Title
IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
Journal
Reference
Authors
Qu F, Gao H, Zhu S, Shi P, Zhang Y, Liu Y, Jallal B, Yao Y, Shi Y, Qian Y
Title
TRAF6-dependent Act1 phosphorylation by the IkappaB kinase-related kinases suppresses interleukin-17-induced NF-kappaB activation.
Journal
Reference
Authors
Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS
Title
Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.
Journal
Related pathway
hsa04060 Cytokine-cytokine receptor interaction
KO pathway